MedTrace Logo

Procalcitonin at Zero and 24 Hours as a Prognostic Factor in Patients With Pneumonia

NCT03711227 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 185

Last updated 2024-11-29

No results posted yet for this study

Summary

Procalcitonin levels checked initially and at 24 hours will correlate with disease severity, morbidity, and mortality. Patients who have a higher procalcitonin level initially and at 24 hours will likely have higher qSOFA scores, longer lengths of stay, longer duration of antibiotics and higher 30 day mortality rates.

Conditions

Interventions

DIAGNOSTIC_TEST

Procalcitonin lab test

A procalcitonin order bundle will be created for admitted patients with pneumonia. This prepopulated bundle includes an initial and 24 hour procalcitonin level.

Sponsors & Collaborators

Principal Investigators

  • Michelino Mancini, DO · Lakeland Hospitals at St. Joseph and Niles

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-17
Primary Completion
2019-08-01
Completion
2019-08-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03711227 on ClinicalTrials.gov